| 86R14038 LHC-D  
---|---  
|  By: Johnson of Harris | H.B. No. 2576  
---  
|  A BILL TO BE ENTITLED  
|  AN ACT  
| relating to prescribing and dispensing certain controlled  
| substances to patients diagnosed with sickle cell anemia.  
|  BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:  
|  SECTION 1. Sections 481.0765(a) and (b), Health and Safety  
| Code, are amended to read as follows:  
|  (a) A prescriber is not subject to the requirements of  
| Section 481.0764(a) if:  
|  (1) the patient has been diagnosed with cancer _or_  
| _sickle cell anemia_ or the patient is receiving hospice care; and  
|  (2) the prescriber clearly notes in the prescription  
| record that the patient was diagnosed with cancer _or sickle cell_  
| _anemia_ or is receiving hospice care, as applicable.  
|  (b) A dispenser is not subject to the requirements of  
| Section 481.0764(a) if it is clearly noted in the prescription  
| record that the patient has been diagnosed with cancer _or sickle_  
| _cell anemia_ or is receiving hospice care.  
|  SECTION 2. The change in law made by this Act applies only  
| to a prescription issued on or after the effective date of this Act.  
| A prescription issued before the effective date of this Act is  
| governed by the law in effect on the date the prescription is  
| issued, and the former law is continued in effect for that purpose.  
|  SECTION 3. This Act takes effect September 1, 2019.

